SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001437749-21-002709
Filing Date
2021-02-12
Accepted
2021-02-12 12:00:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G burr20210205_sc13g.htm SC 13G 78752
  Complete submission text file 0001437749-21-002709.txt   80435
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-50118 | Film No.: 21624580
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 314 COMMONWEALTH AVENUE #4 BOSTON MA 02115
Business Address 314 COMMONWEALTH AVENUE #4 BOSTON MA 02115 617-410-4770
Burrage Capital Management LLC (Filed by) CIK: 0001796461 (see all company filings)

IRS No.: 272863804
Type: SC 13G